Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus

References

Page 1

	Year	Citations
Derivation of the sledai. A disease activity index for lupus patients Claire Bombardier, Dafna D. Gladman, Murray B. Urowitz, Arthritis & Rheumatism	1992	4.5K
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. Peter McLaughlin, A.J. Grillo-López, Brian K. Link, Journal of Clinical Oncology	1998	2.8K
Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis Jonathan Edwards, L Szczepański, Jacek Szechiński, New England Journal of Medicine	2004	2.6K
Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease Filip Baert, Maja Noman, Séverine Vermeire, New England Journal of Medicine	2003	2K
Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus Matthew H. Liang, Steven A. Socher, Martin G. Larson, Arthritis & Rheumatism	1989	791
B cell depletion as a novel treatment for systemic lupus erythematosus: A phase I/II dose‐escalation trial of rituximab R. John Looney, Jennifer H. Anolik, Debbie Campbell, Arthritis & Rheumatism	2004	772
Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity Peter E. Lipsky Nature Immunology Autoimmune DiseaseSystemic Lupus ErythematosusSystemic Lupus Erythematosus TreatmentLupusAutoantibody Production	2001	700
Disturbed Peripheral B Lymphocyte Homeostasis in Systemic Lupus Erythematosus Marcus Odendahl, Annett M. Jacobi, Arne Hansen, The Journal of Immunology	2000	632
The Innate Mononuclear Phagocyte Network Depletes B Lymphocytes through Fc Receptor–dependent Mechanisms during Anti-CD20 Antibody Immunotherapy Junji Uchida, Yasuhito Hamaguchi, Julie A. Oliver, The Journal of Experimental Medicine	2004	627
An open study of B lymphocyte depletion in systemic lupus erythematosus Maria Leandro, Jonathan Edwards, Geraldine Cambridge, Arthritis & Rheumatism	2002	576

Page 1